Rev Cuid. 2026; 17(2): 6342
https://doi.org/10.15649/cuidarte.6342
EDITORIAL
Highlights
How to cite this article: Sierra-Castillo Santiago, Aristizábal-Colorado David, Reyes-Sarmiento Martha Eugenia. Artificial intelligence in healthcare in Latin America and Colombia: bridging gaps and leveraging opportunities. Revista Cuidarte. 2026;17(2):e6342. https://doi.org/10.15649/cuidarte.6342
Artificial intelligence: An opportunity amid structural gaps
Artificial intelligence (AI) is rapidly transforming multiple fields, particularly medicine and the health sciences, not only as a technological innovation but also as a potential shift in how clinical decisions are made, healthcare services are organized, and health systems are structured1. From diagnostic algorithms and predictive models to the recent emergence of generative models and generative AI tools, AI has evolved from isolated applications into technologies capable of reshaping clinical care processes as well as operational and administrative functions related to healthcare delivery2-5. The exponential advancement of this technology has generated considerable expectations regarding its potential to improve quality, efficiency, and access to healthcare, while also raising important concerns about safety, equity, governance, and accountability6.
As health systems begin to adopt and explore the use of AI, it is becoming increasingly clear that the analysis of these technologies can no longer focus solely on the technical capabilities of algorithms. The more critical question is whether AI can be effectively integrated to strengthen health systems and how this can be achieved, given its potential to help reduce structural gaps. However, inappropriate implementation carries the risk of reproducing and even amplifying pre-existing inequalities, particularly in settings such as Latin American countries, where structural barriers remain pervasive, including those observed in Colombia7,8.
This question is particularly important in Latin America, where health systems face institutional fragmentation, health workforce shortages, financial constraints, and persistent gaps in access to care9,10. In this context, AI represents not only a frontier technological innovation but also a potential tool for expanding capacity in areas where structural limitations currently exist10.
Several studies have demonstrated the utility of machine learning–based tools for specific diagnostic tasks, clinical risk prediction, and support for repetitive processes8,11,12. More recently, the expansion of generative AI models has created new opportunities in clinical documentation, medical education, conversational support, and the analysis of complex information. These applications are enabled by advanced deep learning capabilities, the processing of large volumes of data, and the development of models capable of generating content and supporting decision-making processes in complex environments13,14.
However, technological potential alone does not guarantee improvements in health outcomes. The implementation of AI in healthcare is, fundamentally, a sociotechnical challenge3,10,15. The performance of AI models is important, but so are data quality, regulatory frameworks, institutional trust, and the readiness of health systems and their stakeholders to adopt these technologies4,10-12,16. Indeed, the healthcare sector is being reshaped by one of the driving forces of the Fourth Industrial Revolution, and whether this transformation unfolds successfully way will depend on those responsible for implementing it: governments and health systems.
Artificial intelligence at a crossroads: closing or widening gaps
In Latin America, AI has the potential to become a tool for reducing long-standing inequities or, if implemented without appropriate safeguards, a mechanism capable of deepening them1,17. This tension reflects one of the major challenges currently facing the integration of these technologies into healthcare. Limitations related to interoperability, digital maturity, data representativeness, and institutional capacity persist and are closely shaped by the heterogeneity of the region’s health systems. In addition, a large proportion of technological developments originate outside Latin America, raising important questions about their external validity, technological sovereignty, and the appropriateness of their application in local contexts10,12,15.
The risks are well recognized: algorithmic bias, opacity in decision-making, digital exclusion, systematic errors affecting underrepresented populations, and new forms of technological dependence. However, the opportunities are equally evident: improving access to care, optimizing resource allocation, strengthening continuity of care, and supporting complex clinical decision-making10,15. In this context, particularly in Latin America, AI could help improve the quality of care, expand access (one of the region’s most persistent challenges), and mitigate the impact of shortages of specialized healthcare personnel, thereby promoting more timely care delivery. These effects could, in turn, reduce the burden on health systems and associated costs, while also influencing social determinants relevant to health across the region10,15.
At present, Latin America lacks the computing capacity required to manage large volumes of data, as well as the information technology needed to integrate, adopt, and use AI effectively in the healthcare sector. Across the region, supercomputing infrastructure remains limited compared with that of more technologically advanced regions, restricting the analytical capacity and scalability of these tools. Consequently, without investment in infrastructure, and in policies designed to support its implementation, the potential of AI to transform health systems will remain constrained10,11,14,15 Figure 1.
Figure 1. Artificial intelligence as a crossroads for health systems in Latin
America
Artificial intelligence (AI) can either amplify structural gaps or help close them, depending on enabling conditions such as data governance, regulation, ethical frameworks, human resources for health, and local validation. (Figure created with the assistance of generative artificial intelligence [ChatGPT, OpenAI] for visual design and composition).
Data governance, ethics, and trust as foundational pillars
One of the most important debates surrounding the adoption of AI in healthcare concerns data governance. These technologies rely on robust, longitudinal, and representative clinical data, but they also raise critical questions regarding privacy, informed consent, secondary use of data, and digital sovereignty14,15.
In middle-income countries, these discussions are particularly relevant. It is not only about protecting data but also about determining who controls it, how the value it generates is distributed, and how to avoid new forms of technological dependence18,19. Equally important is the need to address ethical dimensions such as bias, transparency and accountability. In healthcare, these issues are not ancillary considerations but essential requirements for safe implementation19,20.
The emergence of generative AI models has made this discussion even more urgent. Although these technologies offer significant opportunities for clinical and administrative support, they also introduce risks related to plausible errors, unsupervised automation, and cognitive dependence 15. This reinforces the need for innovation and caution to advance hand in hand.
Colombia as an opportunity for responsible innovation
Colombia reflects many of these regional tensions. Although the country has made progress in digitalization and innovation, barriers related to interoperability, fragmentation of clinical information, nascent regulatory frameworks, and heterogeneous institutional capacities remain16.
Recent evidence from Colombian institutions indicates that patients, healthcare administrators, and engineers simultaneously recognize both the transformative potential of AI and the challenges nstitutional trust14,16,20.
This finding suggests that the discussion is not merely technological but also organizational and political. For this very reason, Colombia could make a significant contribution to developing regional models for the responsible implementation of AI in healthcare.
Colombia is making progress toward the integration of AI within the public sector, where initiatives have been put forward to explore its applications across different sectors, including healthcare. However, these initiatives, promoted by the institutions responsible for health regulation, remain limited and lack a clear roadmap for implementation. In this context, the main challenges can be grouped into several key dimensions: data quality, contextual understanding, regulatory frameworks, education and resistance to change, research and development, financial resources, infrastructure and connectivity, as well as scalability16.
Five priorities for a regional agenda
In light of this landscape, a regional agenda for AI in healthcare should prioritize at
least five key
areas10,14,15.
These priorities do not represent an exclusively technological agenda but rather a strategy for directing innovation toward strengthening health systems.
From technological adoption to value creation
Perhaps one of the most important contributions of AI will not be to automate medicine but to help humanize it. Reducing administrative burden, strengthening continuity of care, and freeing up clinical time for the physician-patient relationship may be among its most valuable applications14.
For Latin America, this opportunity carries important strategic implications. The region can either limit itself to adopting technologies designed around external priorities or develop its own models of responsible innovation aimed at addressing local structural challenges7,10,15.
Artificial intelligence will not, by itself, resolve the region’s structural challenges. However, if implemented appropriately, it can become a powerful tool for addressing them. The real challenge is not technological but political, ethical, and institutional14,19.
Ultimately, the question is not whether artificial intelligence will reach Latin American health systems, but whether it will be used to close long-standing gaps or to deepen them. Its impact will depend not only on its technical capabilities but also on the conditions under which it is implemented: data governance, the robustness of regulatory frameworks, validation in local contexts, and the capacity of health systems to integrate it effectively.
In a region marked by structural limitations in access, financing, and institutional capacity, artificial intelligence represents both an opportunity and a risk. Its implementation can contribute to improving the quality of care, optimizing resource use, and expanding access to healthcare; however, it can also reproduce inequities if it is not guided by a framework grounded in equity and public value. In this regard, advancing toward the responsible adoption of AI requires strengthening institutional capacities, investing in infrastructure and health workforce development, and aligning public policies to ensure that these technologies respond to the region’s actual needs.
Conflict of interest: The authors declare that they have no conflicts of interest related to this article.
Funding: The authors received no funding for the conduct of this study.
Use of Artificial Intelligence: Generative artificial intelligence tools (ChatGPT, OpenAI; the latest version available at the time of manuscript preparation) were used exclusively to assist with the design and visual composition of graphical elements. The conceptualization, scientific interpretation, and final review of the content were performed entirely by the authors.
Author contributions: SS-C: Conceptualization; Data Curation; Formal Analysis; Investigation; Methodology; Project Administration; Validation; Visualization; Writing – Original Draft Preparation; Writing – Review & Editing. DA-C: Conceptualization; Investigation; Validation; Supervision; Writing – Review & Editing. MER-S: Conceptualization; Methodology; Supervision; Validation; Writing – Review & Editing.
References
García-Subirats I, Vargas I, Mogollón-Pérez AS, De Paepe P, da Silva MRF, Unger JP, et al. Barriers in access to healthcare in countries with different health systems. A crosssectional study in municipalities of central Colombia and north-eastern Brazil. Soc Sci Med. 2014;106:204-13. https://doi.org/10.1016/j.socscimed.2014.01.054
Rajkomar A, Dean J, Kohane I. Machine learning in medicine. N Engl J Med. 2019;380(14):1347-58. https://doi.org/10.1056/NEJMra1814259
Davenport T, Kalakota R. The potential for artificial intelligence in healthcare. Future Healthc J. 2019;6(2):94-98. https://doi.org/10.7861/futurehosp.6-2-94
Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25:44-56. https://doi.org/10.1038/s41591-018-0300-7
Takita H, Kabata D, Walston SL, Tatekawa H, Saito K, Tsujimoto Y, et al. A systematic review and meta-analysis of diagnostic performance comparison between generative AI and physicians. npj Digit. Med. 2025;8:175. https://doi.org/10.1038/s41746-025-01543-z
Bajwa J, Munir U, Nori A, Williams B. Artificial intelligence in healthcare: transforming the practice of medicine. Future Healthcare Journal. 2021;8(2):e188-e194. https://doi.org/10.7861/fhj.2021-0095
Peters DH, Garg A, Bloom G, Walker DG, Brieger WR, Rahman MH. Poverty and access to health care in developing countries. Annals New York Academy of Sciences. 2008;1136:161-71. https://doi.org/10.1196/annals.1425.011
Younis HA, Eisa TAE, Nasser M, Sahib TM, Noor AA, Alyasiri OM, et al. A systematic review and meta-analysis of artificial intelligence tools in medicine and healthcare: applications, considerations, limitations, motivation and challenges. Diagnostics. 2024;14:109. https://doi.org/10.3390/diagnostics14010109
Gutiérrez JD, Muñoz-Cadena S. 25: Artificial intelligence in Latin America’s public policy cycles. En: Secchi L, Cruz-Rubio CN, editores. Handbook of Public Policy in Latin America. Cheltenham (UK): Edward Elgar Publishing. 2025 p. 405-422. https://doi.org/10.4337/9781035310197.00034
Bakker B, Chen S, Vasilyev D, Bespalova O, Chin M, Kolpakova D, et al. What can artificial intelligence do for stagnant productivity in Latin America and the Caribbean?. Latin American Journal of Central Banking. 2025;100192. https://doi.org/10.1016/j.latcb.2025.100192
Fahim YA, Hasani IW, Kabba S, Ragab WM. Artificial intelligence in healthcare and medicine: clinical applications, therapeutic advances, and future perspectives. Eur J Med Res. 2025;30:848. https://doi.org/10.1186/s40001-025-03196-w
Rios-Garcia W, Sofía F, Silva-Jiménez, Banegas-Báez D, Rios-Garcia AA. Artificial intelligence for chronic disease screening in Latin America and the Caribbean: the diagnostic potential of digital health. J. Med. Syst. 2025;49:82. https://doi.org/10.1007/s10916-025-02218-8
Al-Nafjan A, Aljuhani A, Alshebel A, Alharbi A, Alshehri A. Artificial intelligence in predictive healthcare: a systematic review. J. Clin. Med. 2025;14(19):6752. https://doi.org/10.3390/jcm14196752
Angus DC, Khera R, Lieu T, Liu V, Ahmad FS, Anderson B, et al. AI, health, and health care today and tomorrow: The JAMA Summit Report on Artificial Intelligence. JAMA. 2025;334(18):1650-64. https://doi.org/10.1001/jama.2025.18490
González-Argote J, Alonso-Galbán P, Vitón-Castillo AA, Lepez CO, Castillo-Gonzalez W, Bonardi MC, et al. Trends in scientific output on artificial intelligence and health in Latin America in Scopus. EAI Endorsed Scal Inf Syst. 2023;10(4):e5. vi.3231 https://doi.org/10.4108/eetsis.vi.3231
López DM, Osorio JS. Inteligencia artificial y salud digital en Colombia: panorama de los avances más recientes y retos futuros. Biomédica. 2025;45(3):5-9. https://doi.org/10.7705/biomedica.8248
Roski J, Hamilton BA, Chapman W, Heffner J, Trivedi R, Del Fiol G, et al. How artificial intelligence is changing health and health care. In: National Academy of Medicine, The learning Health System Series, Whicher D, Ahmed M, Israni ST, et al. Artificial intelligence in health care: the hope, the hype, the promise, the peril. National Academies Press (US); 2023. https://www.ncbi.nlm.nih.gov/books/NBK605950/
Feng M, Mishra S, Ma J, Flaxman S, Bhatt S, Car J, et al. Artificial intelligence for public health can harness data for healthier populations. Nat. Health. 2026;1:167-70. https://doi.org/10.1038/s44360-025-00005-w
Castaño Castaño S. La inteligencia artificial en salud pública: oportunidades, retos éticos y perspectivas futuras. Rev Esp Salud Pública. 2025;99(1):12. https://ojs.sanidad.gob.es/index.php/resp/article/view/1006
Garcia A, Girón-Luque F, Roselli D. La integración de la inteligencia artificial en la atención médica: desafíos éticos y de implementación. Univ. Med. 2023;64(3). https://doi.org/10.11144/Javeriana.umed64-3.inte